Glaxosmithkline Plc (GSK) Technical (Analysis) Reports Glaxosmithkline Plc ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Glaxosmithkline Plc (GSK)
Technical Analysis Report for USA stock GSK Glaxosmithkline Plc. Dated: 01 Nov 2024 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock GSK Glaxosmithkline Plc then click here. or read Experts views on Glaxosmithkline Plc or Forecast & share price targets of Glaxosmithkline Plc
Glaxosmithkline Plc Opened at 37.59 and Closed at: 36.88, which is 0.33% of previous session's close. It moved within a range of 36.85 and 37.60
The session was a Bearish session with an average volume of 6877200, which is -76.26% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the long term trend of the stock remains negative and in a downtrend.
Support for tomorrow is 36.49 and resistance for tomorrow is 37.24
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 36.62, 36.36 resistance for tomorrow's hourly charts is 37.37, 37.86
10 Day SMA for Glaxosmithkline Plc (GSK) is 37.61 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Glaxosmithkline Plc (GSK) is 38.29 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Glaxosmithkline Plc (GSK) is 40.69 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 40.27 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Glaxosmithkline Plc is 41.25 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Glaxosmithkline Plc is at 38.29 and 200 DMA is at 41.25, while 50 DMA and 100 DMA are at 40.69 and 40.27 respectively
Glaxosmithkline Plc (GSK) moving average of 20 SMA is at 38.29 and 20 EMA is at 38.3
| Date | Closing Price | 20 SMA | 20 EMA |
| 01 Fri Nov | 36.88 | 38.29 | 38.3 |
| 31 Thu Oct | 36.76 | 38.39 | 38.45 |
| 30 Wed Oct | 37.01 | 38.47 | 38.63 |
| 29 Tue Oct | 38.17 | 38.59 | 38.8 |
| 28 Mon Oct | 37.88 | 38.7 | 38.87 |
| 25 Fri Oct | 37.52 | 38.85 | 38.97 |
Glaxosmithkline Plc (GSK) moving average of 50 SMA is at 40.69 and 50 EMA is at 39.59
| Date | Closing Price | 50 SMA | 50 EMA |
| 01 Fri Nov | 36.88 | 40.69 | 39.59 |
| 31 Thu Oct | 36.76 | 40.81 | 39.7 |
| 30 Wed Oct | 37.01 | 40.92 | 39.82 |
| 29 Tue Oct | 38.17 | 41.02 | 39.93 |
| 28 Mon Oct | 37.88 | 41.1 | 40 |
| 25 Fri Oct | 37.52 | 41.17 | 40.09 |
Glaxosmithkline Plc (GSK) moving average of 100 SMA is at 40.27 and 100 EMA is at 40.26
| Date | Closing Price | 100 SMA | 100 EMA |
| 01 Fri Nov | 36.88 | 40.27 | 40.26 |
| 31 Thu Oct | 36.76 | 40.31 | 40.33 |
| 30 Wed Oct | 37.01 | 40.35 | 40.4 |
| 29 Tue Oct | 38.17 | 40.39 | 40.47 |
| 28 Mon Oct | 37.88 | 40.42 | 40.52 |
| 25 Fri Oct | 37.52 | 40.45 | 40.57 |
Glaxosmithkline Plc (GSK) moving average of 200 SMA is at 41.25 and 200 EMA is at 40.17
| Date | Closing Price | 200 SMA | 200 EMA |
| 01 Fri Nov | 36.88 | 41.25 | 40.17 |
| 31 Thu Oct | 36.76 | 41.26 | 40.2 |
| 30 Wed Oct | 37.01 | 41.27 | 40.23 |
| 29 Tue Oct | 38.17 | 41.28 | 40.26 |
| 28 Mon Oct | 37.88 | 41.28 | 40.28 |
| 25 Fri Oct | 37.52 | 41.29 | 40.3 |
Tenet Healthcare has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Tenet Healthcare, about 6.66% more returns!
Glaxosmithkline Plc has performed better than Eli Lilly in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Glaxosmithkline Plc has performed better than Civitas Solutions in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Abbvie Inc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Abbvie Inc, about 9.66% more returns!
Xeris Pharmaceuticals has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Xeris Pharmaceuticals, about 14.77% more returns!
Trinity Biotech has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Trinity Biotech, about 28.79% more returns!
Theravance Biopharma has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Theravance Biopharma, about 7.39% more returns!
Prothena Corporation has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Prothena Corporation, about 4.89% more returns!
Meiragtx Holdings has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Meiragtx Holdings, about 45.89% more returns!
Karyopharm Therapeutics has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Karyopharm Therapeutics, about 7.98% more returns!
Henry Schein has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Henry Schein, about 6.07% more returns!
Glaxosmithkline Plc has performed better than Astrazeneca Plc in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Alphatec Holdings has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Alphatec Holdings, about 52.25% more returns!
Argenx Se has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Argenx Se, about 18.45% more returns!
Amneal Pharmaceuticals has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Amneal Pharmaceuticals, about 4.88% more returns!
Alector Inc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Alector Inc, about 15.59% more returns!
Adma Biologics has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Adma Biologics, about 0.52% more returns!
Abeona Therapeutics has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Abeona Therapeutics, about 0.1% more returns!
Glaxosmithkline Plc Technical analysis of indicators
Price action analysis of Glaxosmithkline Plc (GSK) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Glaxosmithkline Plc stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Glaxosmithkline Plc in short term and the sell signal is strong.
Glaxosmithkline Plc Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Glaxosmithkline Plc in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Glaxosmithkline Plc is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 37.39 and Glaxosmithkline Plc GSK stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Glaxosmithkline Plc GSK stock. Volume based technical analysis of Glaxosmithkline Plc GSK stock is negative.
Glaxosmithkline Plc Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock GSK Glaxosmithkline Plc These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And GSK Experts View which covers a lot of information including buying and selling signals
GSK future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Glaxosmithkline Plc or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Glaxosmithkline Plc (GSK) Technical (Analysis) Reports Glaxosmithkline Plc ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance